Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Speerstra, F"'
Autor:
Speerstra, F., Van de Putte, L. B. A., Rasker, J. J., Reekers, P., Vandenbroucke, J. P., van de Putte, L B
Publikováno v:
Scandinavian Journal of Rheumatology; 1984, Vol. 13 Issue 4, p363-368, 6p
Autor:
Speerstra, F., Riel, P. L. C. M., Reekers, P., Putte, L. B. A., Vandenbroucke, J. P., Centres, Collaborating
Publikováno v:
Tissue Antigens; Jul1986, Vol. 28 Issue 1, p1-7, 7p
Publikováno v:
Tissue Antigens; Jul1985, Vol. 26 Issue 1, p35-40, 6p
Autor:
Stenger, AAME, Van Leeuwen, MA, Houtman, PM, Bruyn, GAW, Speerstra, F, Barendsen, BC, Velthuysen, E, Van Rijswijk, MH
Publikováno v:
British Journal of Rheumatology; Nov1998, Vol. 37 Issue 11, p1157-1163, 7p
Early effective suppression of inflammation in rheumatoid arthritis reduces radiographic progression
Autor:
Rijswijk, M. van, Houtman, P., Bruyn, G., Speerstra, F., Velthuysen, E., Stenger, A., Leeuwen, M. van, Barendsen, B.
Publikováno v:
Rheumatology; November 1998, Vol. 37 Issue: 11 p1157-1163, 7p
Publikováno v:
Europe PubMed Central
By means of a case-control study we investigated the association between HLA phenotypes and the development of proteinuria after aurothioglucose or D-penicillamine treatment in patients with rheumatoid arthritis (RA). HLA-DR3 was markedly increased i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::c72d770b9793bf324e71bcbb750ad4ca
https://pubmed.ncbi.nlm.nih.gov/6420562
https://pubmed.ncbi.nlm.nih.gov/6420562
Autor:
Speerstra, F.
Contains fulltext : mmubn000001_00049576x.pdf (Publisher’s version ) (Open Access) Promotor : L. van de Putte 119 p.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::dc6bfd76c23a07f195a6f0376427af36
https://hdl.handle.net/2066/113174
https://hdl.handle.net/2066/113174
Autor:
Speerstra, F., Boerboom, A.M.Th., van de Putte, L.B.A., van Beusekom, H.J., Kruysen, M.W.M., Vandenbroucke, J.P.
Publikováno v:
Annals of the Rheumatic Diseases 41 (1982) Suppl. 1
Annals of the Rheumatic Diseases, 41(Suppl. 1), 37-39
Annals of the Rheumatic Diseases, 41(Suppl. 1), 37-39
Our experience with azathioprine in the treatment of rheumatoid arthritis covers ten years, during which 91 rheumatoid patients (66 female and 25 male) received this drug, with a median treatment period of 36 months. Total follow-up experience, durin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::8537a5169b9d353263cd4d77e76450a5
https://research.wur.nl/en/publications/side-effects-of-azathioprine-treatment-in-rheumatoid-arthritis-an
https://research.wur.nl/en/publications/side-effects-of-azathioprine-treatment-in-rheumatoid-arthritis-an
Autor:
van de Putte, L B, Speerstra, F, van Riel, P L, Boerbooms, A M, van't Pad Bosch, P J, Reekers, P
Publikováno v:
Annals of the Rheumatic Diseases; Dec1986, Vol. 45 Issue 12, p1004-1006, 3p, 2 Charts
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.